Total number of protein in "GO:0099240" GO term: 77
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABHD17A_ENST00000292577 | ABHD17A | Q96GS6 | Alpha/beta hydrolase domain-containing protein 17A | chr19 | GO:0099240 | Not Cancer Driver | No | 35 | 0.113 | 20 | 5 | 0.25 | 0 |
| ADAM23 | ADAM23 | O75077 | Disintegrin and metalloproteinase domain-containing protein 23 | chr2 | GO:0099240 | Not Cancer Driver | No | 175 | 0.21 | 162 | 26 | 0.16 | 0 |
| ADCY8 | ADCY8 | P40145 | Adenylate cyclase type 8 | chr8 | GO:0099240 | Not Cancer Driver | No | 419 | 0.335 | 215 | 38 | 0.177 | 0 |
| ADORA1 | ADORA1 | P30542 | Adenosine receptor A1 | chr1 | GO:0099240 | Not Cancer Driver | No | 64 | 0.196 | 12 | 4 | 0.333 | 0 |
| ADORA2A | ADORA2A | P29274 | Adenosine receptor A2a | chr22 | GO:0099240 | Not Cancer Driver | No | 61 | 0.148 | 93 | 11 | 0.118 | 0 |
| ADRA1A_ENST00000380573 | ADRA1A | P35348 | Alpha-1A adrenergic receptor | chr8 | GO:0099240 | Not Cancer Driver | No | 130 | 0.279 | 40 | 8 | 0.2 | 0 |
| ADRA2A | ADRA2A | P08913 | Alpha-2A adrenergic receptor | chr10 | GO:0099240 | Not Cancer Driver | No | 67 | 0.144 | 161 | 10 | 0.062 | 0 |
| APH1A | APH1A | Q96BI3 | Gamma-secretase subunit APH-1A | chr1 | GO:0099240 | Not Cancer Driver | No | 32 | 0.121 | 0 | 0 | 0.0 | 0 |
| ATP2B1_ENST00000261173 | ATP2B1 | P20020 | Plasma membrane calcium-transporting ATPase 1 | chr12 | GO:0099240 | Not Cancer Driver | No | 143 | 0.117 | 293 | 42 | 0.143 | 0 |
| ATP2B2 | ATP2B2 | Q01814 | Plasma membrane calcium-transporting ATPase 2 | chr3 | GO:0099240 | Not Cancer Driver | No | 248 | 0.2 | 360 | 82 | 0.228 | 0 |
| ATP2B3_ENST00000349466 | ATP2B3 | Q16720 | Plasma membrane calcium-transporting ATPase 3 | chrX | GO:0099240 | Census | Yes | 245 | 0.201 | 328 | 74 | 0.226 | 2 |
| CADM3_ENST00000368125 | CADM3 | Q8N126 | Cell adhesion molecule 3 | chr1 | GO:0099240 | Not Cancer Driver | No | 120 | 0.302 | 170 | 65 | 0.382 | 0 |
| CANX_ENST00000504734 | CANX | P27824 | Calnexin | chr5 | GO:0099240 | Not Cancer Driver | No | 65 | 0.11 | 334 | 38 | 0.114 | 0 |
| CDH10 | CDH10 | Q9Y6N8 | Cadherin-10 | chr5 | GO:0099240 | Census, Compendium | Yes | 496 | 0.629 | 287 | 179 | 0.624 | 0 |
| CDH2 | CDH2 | P19022 | Cadherin-2 | chr18 | GO:0099240 | Not Cancer Driver | No | 238 | 0.263 | 461 | 130 | 0.282 | 7 |
| CHRM1 | CHRM1 | P11229 | Muscarinic acetylcholine receptor M1 | chr11 | GO:0099240 | Not Cancer Driver | No | 63 | 0.137 | 131 | 24 | 0.183 | 0 |
| CHRNA6 | CHRNA6 | Q15825 | Neuronal acetylcholine receptor subunit alpha-6 | chr8 | GO:0099240 | Not Cancer Driver | No | 101 | 0.204 | 33 | 6 | 0.182 | 0 |
| CHRNB2 | CHRNB2 | P17787 | Neuronal acetylcholine receptor subunit beta-2 | chr1 | GO:0099240 | Not Cancer Driver | No | 92 | 0.183 | 23 | 2 | 0.087 | 2 |
| CNR1_ENST00000549890 | CNR1 | P21554 | Cannabinoid receptor 1 | chr6 | GO:0099240 | Not Cancer Driver | No | 129 | 0.273 | 9 | 1 | 0.111 | 0 |
| CNTN1 | CNTN1 | Q12860 | Contactin-1 | chr12 | GO:0099240 | Not Cancer Driver | No | 265 | 0.26 | 220 | 50 | 0.227 | 0 |
| CNTN2 | CNTN2 | Q02246 | Contactin-2 | chr1 | GO:0099240 | Not Cancer Driver | No | 155 | 0.149 | 370 | 61 | 0.165 | 0 |
| CNTN5_ENST00000528682 | CNTN5 | O94779 | Contactin-5 | chr11 | GO:0099240 | Not Cancer Driver | No | 380 | 0.345 | 290 | 74 | 0.255 | 0 |
| CNTN6_ENST00000350110 | CNTN6 | Q9UQ52 | Contactin-6 | chr3 | GO:0099240 | Not Cancer Driver | No | 330 | 0.321 | 173 | 59 | 0.341 | 0 |
| CPLX3 | CPLX3 | Q8WVH0 | Complexin-3 | chr15 | GO:0099240 | Not Cancer Driver | No | 26 | 0.165 | 149 | 25 | 0.168 | 0 |
| DLG4_ENST00000399506 | DLG4 | P78352 | Disks large homolog 4 | chr17 | GO:0099240 | Not Cancer Driver | No | 116 | 0.16 | 232 | 55 | 0.237 | 0 |
| DRD1 | DRD1 | P21728 | D(1A) dopamine receptor | chr5 | GO:0099240 | Not Cancer Driver | No | 73 | 0.164 | 30 | 4 | 0.133 | 0 |
| DRD2_ENST00000542968 | DRD2 | P14416 | D(2) dopamine receptor | chr11 | GO:0099240 | Not Cancer Driver | No | 127 | 0.287 | 124 | 45 | 0.363 | 0 |
| EFNB2_ENST00000245323 | EFNB2 | P52799 | Ephrin-B2 | chr13 | GO:0099240 | Not Cancer Driver | No | 42 | 0.126 | 97 | 15 | 0.155 | 0 |
| EFNB3 | EFNB3 | Q15768 | Ephrin-B3 | chr17 | GO:0099240 | Not Cancer Driver | No | 45 | 0.132 | 183 | 22 | 0.12 | 0 |
| EPHA4_ENST00000409938 | EPHA4 | P54764 | Ephrin type-A receptor 4 | chr2 | GO:0099240 | Not Cancer Driver | No | 182 | 0.185 | 140 | 24 | 0.171 | 0 |
| EPHB2 | EPHB2 | P29323 | Ephrin type-B receptor 2 | chr1 | GO:0099240 | Not Cancer Driver | No | 186 | 0.176 | 119 | 17 | 0.143 | 7 |
| ERBB4 | ERBB4 | Q15303 | Receptor tyrosine-protein kinase erbB-4 | chr2 | GO:0099240 | Census, Compendium | Yes | 428 | 0.327 | 323 | 116 | 0.359 | 2 |
| FXYD6_ENST00000260282 | FXYD6 | Q9H0Q3 | FXYD domain-containing ion transport regulator 6 | chr11 | GO:0099240 | Not Cancer Driver | No | 14 | 0.147 | 27 | 4 | 0.148 | 0 |
| GABBR1 | GABBR1 | Q9UBS5 | Gamma-aminobutyric acid type B receptor subunit 1 | chr6 | GO:0099240 | Not Cancer Driver | No | 150 | 0.156 | 142 | 17 | 0.12 | 0 |
| GABRA5_ENST00000355395 | GABRA5 | P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | chr15 | GO:0099240 | Not Cancer Driver | No | 146 | 0.316 | 55 | 14 | 0.255 | 3 |
| GPHN_ENST00000315266 | GPHN | Q9NQX3 | Gephyrin | chr14 | GO:0099240 | Census | Yes | 126 | 0.171 | 305 | 41 | 0.134 | 2 |
| GPM6A_ENST00000393658 | GPM6A | P51674 | Neuronal membrane glycoprotein M6-a | chr4 | GO:0099240 | Not Cancer Driver | No | 83 | 0.299 | 15 | 5 | 0.333 | 0 |
| GRIK4_ENST00000438375 | GRIK4 | Q16099 | Glutamate receptor ionotropic, kainate 4 | chr11 | GO:0099240 | Not Cancer Driver | No | 179 | 0.187 | 74 | 8 | 0.108 | 0 |
| GRIK5_ENST00000593562 | GRIK5 | Q16478 | Glutamate receptor ionotropic, kainate 5 | chr19 | GO:0099240 | Not Cancer Driver | No | 176 | 0.18 | 135 | 9 | 0.067 | 0 |
| GRM3 | GRM3 | Q14832 | Metabotropic glutamate receptor 3 | chr7 | GO:0099240 | Census | Yes | 323 | 0.367 | 8 | 3 | 0.375 | 0 |
| HTR1B | HTR1B | P28222 | 5-hydroxytryptamine receptor 1B | chr6 | GO:0099240 | Not Cancer Driver | No | 91 | 0.233 | 33 | 15 | 0.455 | 0 |
| HTR2A | HTR2A | P28223 | 5-hydroxytryptamine receptor 2A | chr13 | GO:0099240 | Not Cancer Driver | No | 105 | 0.223 | 44 | 8 | 0.182 | 0 |
| KCNA1 | KCNA1 | Q09470 | Potassium voltage-gated channel subfamily A member 1 | chr12 | GO:0099240 | Not Cancer Driver | No | 176 | 0.356 | 69 | 34 | 0.493 | 17 |
| KCNA2_ENST00000638616 | KCNA2 | P16389 | Potassium voltage-gated channel subfamily A member 2 | chr1 | GO:0099240 | Not Cancer Driver | No | 96 | 0.192 | 82 | 16 | 0.195 | 5 |
| KCNA3 | KCNA3 | P22001 | Potassium voltage-gated channel subfamily A member 3 | chr1 | GO:0099240 | Not Cancer Driver | No | 120 | 0.209 | 169 | 16 | 0.095 | 0 |
| KCNC1_ENST00000379472 | KCNC1 | P48547 | Potassium voltage-gated channel subfamily C member 1 | chr11 | GO:0099240 | Not Cancer Driver | No | 91 | 0.178 | 110 | 18 | 0.164 | 1 |
| KCNJ3 | KCNJ3 | P48549 | G protein-activated inward rectifier potassium channel 1 | chr2 | GO:0099240 | Not Cancer Driver | No | 189 | 0.377 | 162 | 64 | 0.395 | 0 |
| KCNJ9 | KCNJ9 | Q92806 | G protein-activated inward rectifier potassium channel 3 | chr1 | GO:0099240 | Not Cancer Driver | No | 47 | 0.12 | 67 | 1 | 0.015 | 0 |
| LRFN3 | LRFN3 | Q9BTN0 | Leucine-rich repeat and fibronectin type-III domain-containing protein 3 | chr19 | GO:0099240 | Not Cancer Driver | No | 77 | 0.123 | 212 | 20 | 0.094 | 0 |
| NCSTN | NCSTN | Q92542 | Nicastrin | chr1 | GO:0099240 | Not Cancer Driver | No | 94 | 0.133 | 72 | 11 | 0.153 | 1 |
| NECTIN1 | NECTIN1 | Q15223 | Nectin-1 | chr11 | GO:0099240 | Not Cancer Driver | No | 84 | 0.162 | 217 | 36 | 0.166 | 0 |
| NPTN | NPTN | Q9Y639 | Neuroplastin | chr15 | GO:0099240 | Not Cancer Driver | No | 47 | 0.118 | 118 | 9 | 0.076 | 0 |
| NTNG1_ENST00000370073 | NTNG1 | Q9Y2I2 | Netrin-G1 | chr1 | GO:0099240 | Not Cancer Driver | No | 149 | 0.276 | 1 | 0 | 0.0 | 0 |
| NTNG2 | NTNG2 | Q96CW9 | Netrin-G2 | chr9 | GO:0099240 | Not Cancer Driver | No | 91 | 0.172 | 8 | 4 | 0.5 | 7 |
| OPRD1 | OPRD1 | P41143 | Delta-type opioid receptor | chr1 | GO:0099240 | Not Cancer Driver | No | 91 | 0.245 | 30 | 3 | 0.1 | 0 |
| OPRK1_ENST00000520287 | OPRK1 | P41145 | Kappa-type opioid receptor | chr8 | GO:0099240 | Not Cancer Driver | No | 117 | 0.308 | 18 | 5 | 0.278 | 0 |
| OPRM1_ENST00000330432 | OPRM1 | P35372 | Mu-type opioid receptor | chr6 | GO:0099240 | Not Cancer Driver | No | 107 | 0.268 | 58 | 27 | 0.466 | 0 |
| P2RX1 | P2RX1 | P51575 | P2X purinoceptor 1 | chr17 | GO:0099240 | Not Cancer Driver | No | 59 | 0.148 | 14 | 1 | 0.071 | 0 |
| P2RX3 | P2RX3 | P56373 | P2X purinoceptor 3 | chr11 | GO:0099240 | Not Cancer Driver | No | 85 | 0.214 | 15 | 6 | 0.4 | 0 |
| P2RY1 | P2RY1 | P47900 | P2Y purinoceptor 1 | chr3 | GO:0099240 | Not Cancer Driver | No | 60 | 0.161 | 16 | 1 | 0.062 | 0 |
| P2RY4 | P2RY4 | P51582 | P2Y purinoceptor 4 | chrX | GO:0099240 | Not Cancer Driver | No | 66 | 0.181 | 10 | 2 | 0.2 | 0 |
| PCDH17 | PCDH17 | O14917 | Protocadherin-17 | chr13 | GO:0099240 | Compendium | Yes | 399 | 0.344 | 643 | 210 | 0.327 | 0 |
| PRRT2_ENST00000645336 | PRRT2 | Q7Z6L0 | Proline-rich transmembrane protein 2 | chr16 | GO:0099240 | Not Cancer Driver | No | 45 | 0.132 | 268 | 32 | 0.119 | 7 |
| PSEN1 | PSEN1 | P49768 | Presenilin-1 | chr14 | GO:0099240 | Not Cancer Driver | No | 61 | 0.131 | 134 | 21 | 0.157 | 96 |
| PTPRD | PTPRD | P23468 | Receptor-type tyrosine-protein phosphatase delta | chr9 | GO:0099240 | Census, Compendium | Yes | 577 | 0.302 | 747 | 219 | 0.293 | 0 |
| RGS7BP | RGS7BP | Q6MZT1 | Regulator of G-protein signaling 7-binding protein | chr5 | GO:0099240 | Not Cancer Driver | No | 49 | 0.191 | 166 | 31 | 0.187 | 0 |
| SCN10A | SCN10A | Q9Y5Y9 | Sodium channel protein type 10 subunit alpha | chr3 | GO:0099240 | Not Cancer Driver | No | 513 | 0.262 | 435 | 131 | 0.301 | 2 |
| SCN2A_ENST00000637266 | SCN2A | Q99250 | Sodium channel protein type 2 subunit alpha | chr2 | GO:0099240 | Not Cancer Driver | No | 502 | 0.25 | 435 | 133 | 0.306 | 65 |
| SLC1A2 | SLC1A2 | P43004 | Excitatory amino acid transporter 2 | chr11 | GO:0099240 | Not Cancer Driver | No | 77 | 0.134 | 81 | 7 | 0.086 | 3 |
| SLC6A11 | SLC6A11 | P48066 | Sodium- and chloride-dependent GABA transporter 3 | chr3 | GO:0099240 | Not Cancer Driver | No | 116 | 0.184 | 39 | 2 | 0.051 | 0 |
| SLC6A1_ENST00000643498 | SLC6A1 | P30531 | Sodium- and chloride-dependent GABA transporter 1 | chr3 | GO:0099240 | Not Cancer Driver | No | 119 | 0.199 | 24 | 9 | 0.375 | 4 |
| SLC6A3 | SLC6A3 | Q01959 | Sodium-dependent dopamine transporter | chr5 | GO:0099240 | Not Cancer Driver | No | 150 | 0.242 | 31 | 8 | 0.258 | 2 |
| SLC6A4_ENST00000401766 | SLC6A4 | P31645 | Sodium-dependent serotonin transporter | chr17 | GO:0099240 | Not Cancer Driver | No | 101 | 0.16 | 73 | 12 | 0.164 | 0 |
| SLC6A5 | SLC6A5 | Q9Y345 | Sodium- and chloride-dependent glycine transporter 2 | chr11 | GO:0099240 | Not Cancer Driver | No | 181 | 0.227 | 169 | 38 | 0.225 | 7 |
| SLC6A9 | SLC6A9 | P48067 | Sodium- and chloride-dependent glycine transporter 1 | chr1 | GO:0099240 | Not Cancer Driver | No | 102 | 0.144 | 65 | 12 | 0.185 | 1 |
| STX1A | STX1A | Q16623 | Syntaxin-1A | chr7 | GO:0099240 | Not Cancer Driver | No | 35 | 0.122 | 136 | 11 | 0.081 | 0 |
| SYT7_ENST00000263846 | SYT7 | O43581 | Synaptotagmin-7 | chr11 | GO:0099240 | Not Cancer Driver | No | 63 | 0.156 | 132 | 25 | 0.189 | 0 |